OneThree Biotech
OB
About
OneThree Biotech is a biology-driven artificial intelligence company that accelerates drug discovery and development. Their platform integrates diverse data types to identify novel targets, optimize compounds for toxicity and efficacy, and discover new therapeutic combinations. They aim to provide deeper mechanistic insights into drug action, improving the accuracy and success rate of preclinical R&D.
Key facts
At-a-glance profile data
- Website
- onethree.bio
- Headquarters
- New York City, United States
- Founded
- 2018
- Total funding
- $3M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 9 Jan 2020 | Seed | $3M | Primary Venture Partners |
Tech stack
Detected on onethree.bio, last scanned 12 Sept 2026. Run your own scan
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has OneThree Biotech raised?
OneThree Biotech has raised a total of $3M in funding. The most recent round on record is Seed.